Back to Search
WILLIAM BURKE, MD
MD
Neurology Physician
NPI: 1184679128Individual
Specialties, Licenses & Credentials
Clinical Trials (1)
1
Linked Trials
0
Recruiting
1
With Results
Research & Publications (20)
Antidepressants for the treatment of depression in people with cancer.
PMID 36999619·Cochrane Database Syst Rev·2023
6-review
Prevention of depression with escitalopram in patients undergoing treatment for head and neck cancer: randomized, double-blind, placebo-controlled clinical trial.
PMID 23788218·JAMA Otolaryngol Head Neck Surg·2013
4-observational
Aggregation of alpha-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine.
PMID 17965867·Acta Neuropathol·2008
7-preclinical
Neurotoxicity of MAO metabolites of catecholamine neurotransmitters: role in neurodegenerative diseases.
PMID 14697885·Neurotoxicology·2004
6-review
3,4-dihydroxyphenylacetaldehyde: a potential target for neuroprotective therapy in Parkinson's disease.
PMID 12769806·Curr Drug Targets CNS Neurol Disord·2003
6-review
3,4-Dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: implications for Parkinson's disease pathogenesis.
PMID 14556942·Brain Res·2003
4-observational
Catecholamine monoamine oxidase a metabolite in adrenergic neurons is cytotoxic in vivo.
PMID 11164826·Brain Res·2001
7-preclinical
Stage IIIA endometrial carcinoma: outcome and predictors of survival.
PMID 19546765·Obstet Gynecol·2009
4-observational
A review of depression in the head and neck cancer patient.
PMID 19606075·Clin Adv Hematol Oncol·2009
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1 JEFFERSON BARRACKS DRIVE, 11G JB BUILDING 1 ROOM 2E23
ST LOUIS, MO 63125 - Phone
- (314) 652-4106
Quick Facts
- NPI
- 1184679128
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile